BEIJING, April 18 /PRNewswire/ -- BioDuro & The National Center for Safety Evaluation of Drugs (NCSED, the "Center") in Beijing announce their receipt of full AAALAC accreditation. BioDuro and the Center collaborate to offer preclinical toxicology and large animal DMPK for clients worldwide.
Dean Rodwell, BioDuro's Vice-President of Toxicology stated "Although we have been operating under this standard for over a year, it is exciting to receive this important, internationally recognized official accreditation. BioDuro is now working closely with the Center to attain US FDA GLP certification and expects to be operating at this level by the third quarter of 2008."
Dr. Li Bo from the National Institute for the Control of Pharmaceutical and Biological Product (NICPBP) mentioned "AAALAC accreditation is a wonderful step as we expand our exceptional services."
The Center's main tasks are to carry out the toxicological tests and preclinical safety evaluation of drugs in the field of non-clinical research and development. It possesses experienced scientific and technical teams in disciplines such as pharmacology, toxicology, laboratory animal services, analytical chemistry, biochemistry, physiology and pathology. It is well equipped with instrumentation and animal facilities and is strictly managed according to Chinese GLP. The Center is currently engaged in toxicological tests and preclinical safety evaluation of drugs, on the basis of drug registration requirements of both domestic and international regulations.
BioDuro is a US-based, fully-integrated, global life science outsourcing services company, committed to creating high-quality, integrated R&D capabilities in China to meet the growing needs of the global biotechnology and pharmaceutical industries. Our functional strengths are in medicinal chemistry, synthetic chemistry, biology, assay development/screening, DMPK and toxicology. We have hired exceptional, experienced people in each discipline from around the world. We have placed a premium on drug discovery experience in the West and have many scientists with such experience. We have built world-class laboratories for each function in Beijing and have unique access to toxicology and large animal DMPK via our collaboration with the Center. Our customers are over 40 pharmaceutical and biotechnology companies including 9 of the top 12 global pharmaceutical companies. Unlike many others, BioDuro's leadership team is built with true expertise across all aspects of drug discovery and a deep understanding of how to build and operate a high quality professional services organization.
For more information on the services offered by BioDuro and The National Center for Safety Evaluation of Drugs please contact BioDuro at 4350 La Jolla Village Drive, Suite 450, San Diego, CA 92121, 1-888-251-1697, firstname.lastname@example.org or visit our website at http://www.bioduro.com.
Copyright©2008 PR Newswire.
All rights reserved